Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongmai Yangxin Pill for slow arrhythmia
ChiCTR1900025781Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Oct 2019
- Countries
- 1
01
Overview
Phase 4 trial of Tongmai Yangxin Pills in bradyarrhythmia, Sinus bradycardia (SB), sick sinus syndrome (SSS) and 1 more (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Dynamic electrocardiogram, Electrocardiogram and 1 more. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
Tongmai Yangxin Pills
03
Conditions
bradyarrhythmiaSinus bradycardia (SB)sick sinus syndrome (SSS)atrioventricular block
Beyond the preview
Go deeper on ChiCTR1900025781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025781.